Molina Healthcare, Inc (NYSE:MOH - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Monday after Mizuho lowered their price target on the stock from $400.00 to $330.00. Mizuho currently has an outperform rating on the stock. Molina Healthcare traded as low as $216.56 and last traded at $219.01, with a volume of 367821 shares. The stock had previously closed at $221.55.
A number of other research analysts have also recently commented on the company. Sanford C. Bernstein began coverage on Molina Healthcare in a research note on Tuesday, April 22nd. They issued an "outperform" rating and a $414.00 price target for the company. Robert W. Baird reaffirmed a "neutral" rating and set a $375.00 target price (up from $331.00) on shares of Molina Healthcare in a research report on Tuesday, April 15th. Baird R W lowered Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Wall Street Zen lowered Molina Healthcare from a "buy" rating to a "hold" rating in a research report on Sunday, June 29th. Finally, Truist Financial raised their target price on Molina Healthcare from $340.00 to $400.00 and gave the stock a "buy" rating in a research report on Friday, April 11th. Eleven investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, Molina Healthcare presently has a consensus rating of "Hold" and a consensus target price of $352.21.
View Our Latest Stock Analysis on MOH
Insider Buying and Selling
In other Molina Healthcare news, CEO Joseph M. Zubretsky sold 87,500 shares of the business's stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the sale, the chief executive officer owned 257,715 shares of the company's stock, valued at $82,484,262.90. The trade was a 25.35% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Richard M. Schapiro sold 669 shares of the business's stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total transaction of $214,414.50. Following the sale, the director directly owned 11,244 shares in the company, valued at $3,603,702. The trade was a 5.62% decrease in their position. The disclosure for this sale can be found here. Insiders own 1.10% of the company's stock.
Institutional Investors Weigh In On Molina Healthcare
A number of hedge funds and other institutional investors have recently bought and sold shares of MOH. Rothschild Investment LLC increased its holdings in shares of Molina Healthcare by 126.3% in the first quarter. Rothschild Investment LLC now owns 86 shares of the company's stock worth $28,000 after purchasing an additional 48 shares during the period. Zions Bancorporation National Association UT purchased a new position in Molina Healthcare in the first quarter worth $29,000. Colonial Trust Co SC grew its position in Molina Healthcare by 930.0% in the fourth quarter. Colonial Trust Co SC now owns 103 shares of the company's stock worth $30,000 after acquiring an additional 93 shares in the last quarter. Deseret Mutual Benefit Administrators grew its position in Molina Healthcare by 60.7% in the first quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock worth $30,000 after acquiring an additional 34 shares in the last quarter. Finally, Elequin Capital LP grew its position in Molina Healthcare by 170.6% in the first quarter. Elequin Capital LP now owns 92 shares of the company's stock worth $30,000 after acquiring an additional 58 shares in the last quarter. Institutional investors own 98.50% of the company's stock.
Molina Healthcare Price Performance
The firm's 50-day moving average is $293.27 and its 200-day moving average is $303.36. The company has a market capitalization of $11.84 billion, a PE ratio of 10.55, a price-to-earnings-growth ratio of 0.93 and a beta of 0.55. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.87.
Molina Healthcare (NYSE:MOH - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.96 by $0.12. Molina Healthcare had a net margin of 2.81% and a return on equity of 28.38%. The business had revenue of $11.15 billion during the quarter, compared to analyst estimates of $10.86 billion. During the same period in the prior year, the business posted $5.73 earnings per share. The company's revenue was up 12.2% on a year-over-year basis. Equities analysts predict that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.
Molina Healthcare Company Profile
(
Get Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.